FDA
approval
· 2023-08-16
FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Camber Pharmaceuticals' generic drospirenone/ethinyl estradiol, making this combined oral contraceptive available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DROSPIRENONE AND ETHINYL ESTRADIOL (DROSPIRENONE AND ETHINYL ESTRADIOL)